Neuralgic amyotrophy

G6_NEURAMYO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G54.5 Hospital discharge: ICD-9 — 3535 Cause of death: ICD-10 — G54.5 Cause of death: ICD-9 — 3535 2 out of 7 registries used, show all original rules.	81
4. Check minimum number of events None	81
5. Include endpoints None	81
6. Filter based on genotype QC (FinnGen only)	77

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G54
Name in latin: Amyotrophia neuralgica

NAME	G6_NEURAMYO
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G545
HD_ICD_9	3535
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G545
COD_ICD_9	3535
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Neuralgic amyotrophy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	398	163	231
Only index persons	371	152	219
Unadjusted period prevalence (%)
Whole population	0.01	0.00	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	52.03	50.89	52.84
Only index persons	51.07	50.12	51.73

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77	33	44
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	60.01	57.52	61.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
78: Matched controls
780

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G54.5

ICD-10 Finland

Neuralgic amyotrophy

+∞

109.3

R4120

NOMESCO Finland

Occupational therapy

17.5

14.0

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

17.5

13.4

N03AX16

ATC

[U] pregabalin

5.3

11.0

G54.9

ICD-10 Finland

Nerve root and plexus disorder, unspecified

+∞

10.7

G54.0

ICD-10 Finland

Brachial plexus disorders

46.5

10.3

N02AX02

ATC

tramadol; systemic, rectal

4.7

10.1

224

TAB00

NOMESCO Finland

Lumbar puncture

10.0

8.6

L08

ICPC

Shoulder symptom/complaint

3.9

7.5

119

N03AX12

ATC

[U] gabapentin; oral

4.5

7.5

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

10.1

6.9

G56.0

ICD-10 Finland

Carpal tunnel syndrome

10.7

6.6

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

75.8

6.5

M54.1

ICD-10 Finland

Radiculopathy

11.4

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

23.93

10.23

1.1

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

15.18

8.77

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

4.45

8.34

1.4

200.00

492.50

titre

—

(3044290) Cell count panel - Cerebral spinal fluid

11.89

7.92

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

13.91

7.37

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

15.73

7.13

1.2

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

15.73

7.13

1.2

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

7.87

6.38

1.1

1.88

3.47

e6/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

7.87

6.38

1.2

343.44

162.50

e6/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

117

3.35

5.83

1.4

1.3

19.00

22.89

iu/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

6.92

4.80

1.0

1.3

—

(42870588) Differential panel, method unspecified - Blood

241

2.61

4.17

7.7

6.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

10.82

4.09

1.1

1.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3.28

3.99

9.6

8.7

1.29

1.42

mmol/l

0.21

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

289

2.58

3.98

2.2

2.1

97.76

93.71

pmol/l

0.21

157

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

101

2.81

3.83

1.3

47.58

7.74

u/ml

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

122

2.70

3.82

5.0

2.6

1.50

3.07

e6/l

0.49

(3005719) IgG [Mass/volume] in Serum or Plasma

3.21

3.69

4.3

3.0

8.99

10.80

g/l

1.10

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

4.38

3.68

1.2

2.0

35.83

37.02

u/l

0.07

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

132

2.60

3.63

5.4

2.4

1.92

1.04

e6/l

0.32

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

5.50

3.49

2.3

1.3

0.18

0.25

g/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

5.50

3.49

2.1

1.4

1.03

1.29

g/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

5.81

3.28

1.4

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.94

3.22

1.1

1.4

—

(3006315) Basophils [#/volume] in Blood

379

2.38

3.10

8.7

6.3

0.05

0.04

e9/l

0.90

330

(3023368) Bacteria identified in Blood by Culture

198

2.27

3.04

6.1

4.7

—

(3029075) Extractable nuclear Ab panel - Serum

10.55

3.02

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

4.82

2.88

1.1

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.98

2.78

1.9

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

383

2.20

2.65

9.0

6.3

2.42

1.90

e9/l

0.39

344

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

4.33

2.65

5.4

3.3

0.00

g/l

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

5.80

2.59

1.3

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

5.80

2.59

1.3

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

7.53

2.58

1.0

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

209

2.11

2.58

6.2

2.7

0.21

0.34

e6/l

0.44

141

(3001604) Monocytes [#/volume] in Blood

376

2.15

2.56

9.0

6.3

0.57

0.60

e9/l

0.38

329

(3013512) EKG study

239

2.04

2.43

3.1

3.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

4.41

2.42

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

303

2.04

2.42

2.9

3.0

—

estimate

—

(3018418) pH of Serum or Plasma

209

2.00

2.25

7.5

4.7

7.40

0.26

154

(1616796) Gas panel - Central venous blood

4.55

2.19

5.3

3.9

—

(40758558) Short blood count panel - Blood

229

1.96

2.16

10.5

6.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3.15

2.15

1.1

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

197

1.95

2.07

2.0

1.7

21.75

22.34

nmol/l

0.09

160

(3029634) Reagin Ab [Titer] in Serum by VDRL

4.77

1.97

1.4

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

4.77

1.97

1.0

1.3

—

(1761868) Lipid panel - Serum or Plasma

277

0.47

1.95

2.7

3.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2.40

1.90

3.5

3.8

61.37

68.41

ml/min/173m2

—

(3002582) Erythrocytes [#/volume] in Urine

237

1.86

1.90

6.4

3.0

56.97

65.21

e6/l

0.06

175

(3004588) Protein electrophoresis panel - Serum or Plasma

2.56

1.87

6.5

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

214

1.84

1.78

3.8

2.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

3.52

1.78

1.5

1.1

—

(40768797) Stomach Pathology biopsy report

2.11

1.78

1.4

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

4.03

1.74

9.6

4.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

4.03

1.74

1.2

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

4.03

1.74

1.2

1.5

—

(3000991) Gas panel - Venous blood

2.28

1.71

12.0

9.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

263

1.77

1.67

5.6

3.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

141

1.90

1.66

3.1

1.5

2.24

2.73

g/l

0.50

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

166

1.85

1.66

3.1

2.4

—

(3019977) pH of Arterial blood

2.08

1.65

9.5

15.1

7.43

7.42

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.03

1.56

2.3

1.7

—

(3021589) Normoblasts [#/volume] in Blood

315

1.72

1.53

15.7

12.3

0.00

e9/l

0.50

253

(3018095) Leukocytes [#/volume] in Urine

268

1.72

1.53

7.8

3.6

44.17

72.32

e6/l

0.30

185

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.54

1.51

3.8

3.1

23.78

24.45

mmol/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.00

1.51

2.3

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

138

1.83

1.47

3.4

3.8

181.29

305.30

ng/l

0.22

112

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.16

1.35

1.3

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.50

1.33

3.0

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

142

1.77

1.33

3.2

2.7

2.48

2.44

mmol/l

0.57

130

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.51

1.27

1.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.51

1.27

1.7

2.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

224

1.64

1.24

2.6

3.2

1244.92

1163.37

ng/l

0.04

187

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

105

1.79

1.18

2.3

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2.60

1.17

2.2

2.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

1.91

1.15

4.2

4.6

2.31

1.92

0.58

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

123

1.72

1.13

2.3

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

674

2.29

1.11

28.9

16.3

25.87

24.27

mg/l

0.13

552

(3042936) Bacteria identified in Isolate by Culture

107

1.75

1.11

2.8

2.5

—

(3026782) Osmolality of Urine

133

1.68

1.08

3.7

2.8

539.45

544.29

mosm/kgh2o

0.04

119

(3000330) Specific gravity of Urine by Test strip

2.16

1.06

1.3

3.1

1.01

1.02

ratio

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.36

1.05

2.8

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.94

1.03

2.1

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

118

1.68

1.02

2.3

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.86

0.98

1.8

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

155

1.58

0.95

4.6

2.5

3.22

2.60

e6/l

0.20

145

(3037467) Urinalysis macro (dipstick) panel - Urine

465

1.52

0.90

5.1

4.4

—

(40768443) Skin Pathology biopsy report

2.08

0.89

1.5

1.2

—

(3019060) Gas panel - Arterial blood

1.82

0.85

2.3

15.3

—

(3022313) Gas panel - Capillary blood

1.95

0.83

4.2

4.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.75

0.80

1.7

2.1

—

(3032080) INR in Blood by Coagulation assay

321

1.43

0.78

12.2

14.3

1.12

1.26

inr

1.68

260

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2.25

0.77

3.2

2.3

186.80

213.87

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.25

0.77

1.8

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2.15

0.76

3.0

2.2

92.80

91.21

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

661

1.82

0.75

4.5

5.2

5.86

5.99

mmol/l

0.31

608

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1.91

0.69

1.2

1.6

—

0.11

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

157

1.46

0.69

2.6

1.8

0.81

1.25

mg/l

0.73

133

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.84

0.67

1.8

2.1

—

(40768804) Tissue Pathology biopsy report

299

1.38

0.66

1.9

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.59

0.64

2.8

1.7

—

(40768793) Breast Pathology biopsy report

0.00

0.61

0.0

1.4

—

(3022145) Colonoscopy Study observation

1.59

0.60

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.53

0.60

11.4

8.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

212

0.69

0.59

2.8

3.0

0.00

estimate

—

(36660697) Celiac disease serology panel - Serum

1.56

0.57

1.4

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

426

1.33

0.53

3.2

3.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.48

0.52

1.2

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

397

1.32

0.52

4.0

3.6

0.00

estimate

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.52

0.51

2.2

2.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

280

1.31

0.50

4.0

3.8

18.56

36.94

ng/l

0.92

198

(3021601) Nitrite [Presence] in Urine by Test strip

389

1.30

0.49

4.0

3.5

0.00

estimate

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

186

1.34

0.48

3.4

3.0

0.59

0.76

ug/l

0.62

128

(3002256) Pathology report gross observation

1.47

0.48

1.4

1.2

—

(3019150) Specific gravity of Urine by Refractometry

172

0.71

0.47

4.1

3.6

1.02

kg/l

—

110

(3014576) Chloride [Moles/volume] in Serum or Plasma

104

1.42

0.47

13.1

8.1

103.57

104.06

mmol/l

0.12

104

(3035350) Ketones [Presence] in Urine by Test strip

392

1.28

0.45

4.0

3.6

0.00

19.33

estimate

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.48

0.44

1.3

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1.60

0.43

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.41

0.0

1.7

—

1208.61

—

(3011985) Renin [Units/volume] in Plasma

0.00

0.41

0.0

1.1

—

17.53

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.41

0.0

1.7

—

10.67

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

315

1.27

0.41

1.9

2.0

1.30

1.34

mmol/l

0.13

263

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.41

0.0

4.5

—

57.44

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.44

0.41

2.1

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.9

—

(3020891) Body temperature

1.46

0.40

2.8

4.1

37.00

36.92

°c

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.46

0.40

1.0

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

293

0.78

0.40

3.6

3.5

0.00

estimate

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.39

0.0

4.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

1.41

0.39

1.2

138.04

155.65

u/ml

—

(40761536) Microorganisms panel - Urine sediment

1.33

0.31

3.9

3.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

245

1.22

0.31

4.2

4.6

23.12

21.40

0.17

126

(3000492) Spirometry study

1.34

0.27

1.5

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.6

—

1.35

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

3.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.21

0.0

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

2.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

1.23

0.17

1.3

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

102

1.21

0.16

1.9

1.6

—

(3026008) Bacteria identified in Urine by Culture

190

1.14

0.14

3.8

3.0

—

(3015736) pH of Urine

318

1.12

0.14

4.1

3.1

6.11

6.26

0.42

178

(40760892) CBC W Ordered Manual Differential panel - Blood

171

1.15

0.14

2.9

6.1

—

(3029937) Albumin [Presence] in Urine by Test strip

227

0.90

0.11

3.8

3.7

0.00

estimate

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.11

0.08

1.5

1.4

—

(3012516) Albumin [Mass/volume] in Urine

226

1.09

0.08

4.4

3.6

122.06

65.22

mg/l

0.26

158

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.10

0.07

2.0

1.9

1.58

1.53

—

(3020682) Albumin/Creatinine [Ratio] in Urine

238

1.07

0.06

4.8

4.2

17.18

9.48

mg/mmol

0.24

163

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.89

0.00

3.8

3.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

-0.00

0.0

5.6

—

29.10

—

(4035726) Immunohistochemistry procedure

0.87

-0.00

1.0

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.86

-0.00

1.2

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

113.38

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.4

—

3.98

—

(3003694) ABO and Rh group [Type] in Blood

180

1.00

-0.00

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

12.8

—

11.32

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

9.3

—

877.33

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

15.2

—

15.24

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

5.2

—

1.50

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

194.36

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

4.3

—

48.81

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

-0.00

0.0

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

12.60

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.1

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

0.00

-0.00

0.0

2.8

—

2.20

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

18.3

—

1738.22

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.4

—

53.40

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.4

—

1.20

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

3.2

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.4

—

106.11

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEURAMYO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_NEURAMYO.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: G6_NEURAMYO – Neuralgic amyotrophy

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Neuralgic amyotrophy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints